X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-08-22 | MNKD | Galindo Alejandro | EVP Endocrine Business Unit | S - Sale | $3.85 | -4,615 | 777,075 | -1% | -$17,771 | ||||||
2022-07-31 | MNKD | Galindo Alejandro | EVP Endocrine Business Unit | P - Purchase | $2.93 | +5,000 | 781,690 | +1% | +$14,650 | ||||||
2022-02-28 | MNKD | Galindo Alejandro | Chief Commercial Officer | P - Purchase | $2.71 | +36,900 | 576,690 | +7% | +$99,999 | ||||||
| A | 2022-01-31 | MNKD | Galindo Alejandro | Chief Commercial Officer | P - Purchase | $3.17 | +1,804 | 539,790 | 0% | +$5,719 | |||||
2022-01-31 | MNKD | Galindo Alejandro | Chief Commercial Officer | P - Purchase | $3.17 | +2,334 | 540,320 | 0% | +$7,399 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |